Reply: Serum CA-125 and renal impairment in patients undergoing hyperthermic intraperitoneal chemotherapy

Wei Chun Chen, Ting Chang Chang, Hung Hsueh Chou*

*Corresponding author for this work

Research output: Contribution to journalJournal Letter peer-review

1 Scopus citations
Original languageEnglish
Pages (from-to)849-850
Number of pages2
JournalBiomedical Journal
Volume45
Issue number5
DOIs
StatePublished - 10 2022

Keywords

  • CA-125
  • HIPEC
  • Hyperthermic intraperitoneal chemotherapy
  • Ovarian cancer
  • Renal failure

Cite this